MedTrace Logo

A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis

NCT01093118 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2011-01-17

No results posted yet for this study

Summary

The purpose of this study is to determine if a local treatment is effective for the treatment of toenail fungus (distal subungual onychomycosis).

Conditions

  • Distal Subungual Onychomycosis

Interventions

DRUG

TMI-358

Micro implant monthly x 3

DRUG

MMI-467

Micro implant monthly x 3

Sponsors & Collaborators

  • Talima Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Terry Jones, MD · J&S Studies, Inc.

  • Michael Noss, MD · Radiant Research, Inc.

  • Robert Matheson, MD · Oregon Medical Research Center

  • Leonard Swinyer, MD · Dermatology Research Center

  • Stacy Smith, MD · Therapeutics Clinical Research

  • Norman Bystol, MD · Radiant Research, Inc.

  • Jose Mendez, DO · International Dermatology Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01093118 on ClinicalTrials.gov